Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Neuro-Mucormycosis: Lessons From Covid-19-Associated Cases Publisher



Sedaghat N1 ; Etemadifar M2 ; Ghasemi P1 ; Naghizadeh M1 ; Mokari Y3 ; Salari M4 ; Golastani B5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Neurosurgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran
  4. 4. Functional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  5. 5. Department of Cell and Molecular Biology and Microbiology, School of Biological Science and Technology, University of Isfahan, Isfahan, Iran

Source: Current Journal of Neurology Published:2023


Abstract

Background: Scarce data are available on the neurological presentations of coronavirus disease 2019 (COVID-19)-associated mucormycosis (CAM) and COVID-19-unrelated rhino-orbito-cerebral mucormycosis (ROCM). This study aimed to compare the neurological presentations and their associated outcomes in patients with CAM and COVID-19-unrelated ROCM. Methods: In December 2021, a case-control analysis was conducted on the CAM (case group) and COVID-19-unrelated ROCM (control group) referrals of one center in Isfahan, Iran. Confirmed CAM patients from January 2020 to December 2021 constituted the case group, and patients with COVID-19-unrelated ROCM from 2016-2019 constituted the control group. Their data were then analyzed using proper (non) parametric tests and generalized linear models (GLM), therein P-value below 0.05 was considered as the criterion of statistical significance, and the SPSS software was used. Results: After retrieving data on 177 patients with mucormycosis, 78 patients with CAM were included as the case group and 72 patients with COVID-19-unrelated ROCM were included as the control group. Neurological presentations suggestive of second, third, and eighth cranial nerve involvement were more prevalent in the CAM group (all with P < 0.05). The mortality rate in the CAM group was 1.9 times that of the controls (P = 0.01), being explained by higher extent of corticosteroid administration among them. Higher age and presentation with gait ataxia, ptosis, and mydriasis were considered to be predictive of poor prognosis in patients with CAM (all with P < 0.05). © 2023 Iranian Neurological Association, and Tehran University of Medical Sciences Published by Tehran University of Medical Sciences.
Related Docs
View other Related Docs
1. Covid-19 Associated Mucormycosis (Cam) in Kashan, Iran: Clinical Presentations, Risk Factors, Management, and Outcomes, Infectious Diseases (2024)
2. Risk Factors of Covid-19 Associated Mucormycosis in Iranian Patients: A Multicenter Study, BMC Infectious Diseases (2024)
3. Covid-19 Associated Mucormycosis Surge: A Review on Multi-Pathway Mechanisms, Parasite Immunology (2024)
4. Mucormycosis: The International Id-Iri Study, Medical Mycology (2024)
5. The Relationship of Serum Iron and Ferritin Levels With Mucormycosis Infection in Diabetic Patients Having Acute Covid-19 During the Year 2021 in Kermanshah University of Medical Sciences; [بررسی ارتباط بین سطح آهن سرم و فریتین و ابتلا به بیماري موکورمایکوزیس در بیماران مبتلا به کووید- 19 حاد با سابقه دیابت ملیتوس], Tehran University Medical Journal (2024)
6. Case Report: Covid-19-Associated Mucormycosis Co-Infection With Lomentospora Prolificans: The First Case and Review on Multiple Fungal Co-Infections During Covid-19 Pandemic, Frontiers in Medicine (2023)
7. Cerebellitis Following Covid-19 Infection: A Case-Based Systematic Review and Pooled Analysis, Heliyon (2024)
8. Guillain-Barre Syndrome (Gbs) After Severe/Critical Covid-19 or Covid-19 Vaccination, European journal of medical research (2025)
Experts (# of related papers)
View all Related Experts
Vahid Shaygannejad (10)
Seyed Hossein Mirhendi Esfahani (8)
Other Related Docs
9. Clinical and Neuroimaging Characteristics of Ischemic Stroke in Rhino-Orbito-Cerebral Mucormycosis Associated With Covid-19, Clinical Neuroradiology (2023)
10. Cardioembolic Stroke, the Most Common Subtype of Stroke in Covid 19: A Single Center Experience From Isfahan, Iran, Journal of Research in Medical Sciences (2023)
11. Post Covid-19 Infection Neuromyelitis Optica Spectrum Disorder (Nmosd): A Case Report-Based Systematic Review, Multiple Sclerosis and Related Disorders (2022)
12. Self-Reported Safety of the Bbibp-Corv (Sinopharm) Covid-19 Vaccine Among Iranian People With Multiple Sclerosis, Human Vaccines and Immunotherapeutics (2022)
13. A Case of Covid-19-Associated Mucormycosis Due to Lichtheimia Ramosa, Journal of Clinical Laboratory Analysis (2023)
14. Outcome of Covid-19 Infection in Multiple Sclerosis Patients Receiving Disease-Modifying Therapies, Journal of Research in Medical Sciences (2021)
15. Guillain-Barre Syndrome and Covid-19 Vaccine: A Report of Nine Patients, Basic and Clinical Neuroscience (2021)
16. Multiple Sclerosis Is Associated With Worse Covid-19 Outcomes Compared to the General Population: A Population-Based Study, Multiple Sclerosis and Related Disorders (2023)
17. Sars-Cov-2 and Stroke Characteristics: A Report From the Multinational Covid-19 Stroke Study Group, Stroke (2021)
18. Risk Factors of Severe Covid-19 in People With Multiple Sclerosis : A Systematic Review and Meta-Analysis, Revue Neurologique (2022)
19. Neuropsychiatric Manifestations of Covid-19 in Hospitalized Pediatrics: A Multicenter Cross-Sectional Study, Archives of Pediatric Infectious Diseases (2023)
20. Differential Diagnostic Utility of Clinical Laboratory Data in Patients With Severe and Non-Severe Covid-19, Shiraz E Medical Journal (2022)
21. Co-Detection of Human Herpes Viruses in Cerebrospinal Fluid Samples of Pediatric Patients With Multi-System Inflammatory Syndrome: A Single Center Experience in Isfahan, Iran, Archives of Pediatric Infectious Diseases (2024)
22. Predictors of Catching Covid-19 Infection During Pandemic Stage in Patients With Multiple Sclerosis (Ms), International Journal of Preventive Medicine (2022)
23. Risk Factors, Clinical, and Laboratory Characteristics of Patients With a Diagnosis of Covid-19, Journal of Emergency Practice and Trauma (2022)
24. Age-Dependent Clinical Features and Prognosis of Covid-19 Patients, Tanaffos (2021)
25. A Systematic Review on Mucocutaneous Manifestations of Covid-19 in Children, Iranian Journal of Dermatology (2022)
26. The Covid-19 Pandemic: A Systematic Review of the Current Evidence; [Пандемия Covid-19: Систематический Обзор Современных Данных], Russian Journal of Infection and Immunity (2020)
27. Central Nervous System Vasculopathy Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2): A Novel Case Report From Iran, Journal of NeuroVirology (2021)
28. Myasthenia Gravis and Coronavirus Disease 2019: A Report From Iran, Current Journal of Neurology (2021)
29. Microbial and Clinical Epidemiology of Invasive Fungal Rhinosinusitis in Hospitalized Covid-19 Patients, the Divergent Causative Agents, Medical Mycology (2023)
30. Guillain-Barre Syndrome in Patients With Coronavirus Disease-2019: Report of Six Cases and Review of Literature, Current Journal of Neurology (2020)
31. Disease-Modifying Therapies, Outcomes, Risk Factors and Severity of Covid-19 in Multiple Sclerosis: A Menactrims Registry Based Study, Multiple Sclerosis and Related Disorders (2024)
32. Features and Evaluation of Mucormycosis in Covid-19 Patients From Two Referral Hospitals in Iran, Journal of Medical Mycology (2024)
33. Sars-Cov-2 Infection and Spontaneous Spinal Hemorrhage: A Systematic Review, Neurosurgical Review (2023)
34. Covid-19-Associated Mucormycosis in Diabetic Patients: The Tip of an Iceberg, Iranian Journal of Public Health (2022)
35. Epidemiological Features of Covid-19 in Iran, Journal of Research in Medical Sciences (2022)
36. Clinical Display, Diagnostics and Genetic Implication of Novel Coronavirus (Covid-19) Epidemic, European Review for Medical and Pharmacological Sciences (2020)
37. Mortality Rate of Mucormycosis and Its Risk Factors in Hospitalized Patients in Alzahra Hospital, Isfahan, Iran, During 2011-2015, Journal of Isfahan Medical School (2018)
38. Evaluation of Sars-Cov-2 Serum Level in Patients Vaccinated With Sinopharm/Bbibp-Corv With Kidney Transplantation, Transplantation Proceedings (2022)
39. Persistent Cognitive Impairment As a Rare Manifestation of Mild Covid-19 Infection – a Case Series, Romanian Journal of Neurology/ Revista Romana de Neurologie (2022)
40. Covid-19 Associated Mucormycosis and Anbarnesa: Concerning About Important Source of Spores, Iranian Journal of Public Health (2022)
41. Covid-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight With No Bystander Effect?, Multiple Sclerosis and Related Disorders (2021)
42. Covid-19 in Parkinson's Disease Treated by Drugs or Brain Stimulation; [Covid-19 En La Enfermedad De Parkinson Tratada Con Farmacos O Estimulacion Cerebral], Neurologia (2024)
43. Covid-19 Infection and Hospitalization Rate in Iranian Multiple Sclerosis Patients: What We Know by May 2021, Multiple Sclerosis and Related Disorders (2022)
44. A Review of Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2), Iranian Journal of Medical Microbiology (2020)
45. Evidence-Based Prediction of Covid-19 Severity in Hospitalized Children, International journal of clinical practice (2022)
46. Diagnosis of Mucormycosis Using a Simple Duplex Pcr Assay: Analysis of 160 Clinical Samples From Covid-19 Patients, Medical Mycology (2023)
47. Prevalence of Coronavirus Disease 2019 in Patients With Neuromyelitis Optica in Isfahan, Iran, and a Review on Recent Reports and Literature, Current Journal of Neurology (2021)
48. Effectiveness of Corticosteroid Therapy in Patients With Moderate to Severe Coronavirus Disease 2019: A Retrospective Study, Journal of Nephropharmacology (2023)
49. Nervous System Involvement in Covid-19: A Review of the Current Knowledge, Molecular Neurobiology (2021)
50. The Prevalence of Covid-19 Infection in Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Neurological Sciences (2021)